PROVIDA PENSION FUND ADMINISTRATOR

Q1 2020 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Santiago Donoso - CEO Provida
Location
Las Condes, Santiago, Chile
Holdings as of
March 31, 2020
Value $
$2.15B
Num holdings
68
Date filed
9/2/2020, 09:01 AM
Description
Request for Confidential Treatment (5/15/2020): Confidential Treatment Expired on 9/1/2020. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q4 2019 - Jun 1, 2020
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 05-15-2020 pursuant to a request for confidential treatment and for which confidential treatment expired on 09-01-2020.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Elizabeth Bedore Authorized Signatory Whippany, New Jersey 8/1/2020

Please note that this 13F Holdings Report filer is affiliated with MetLife Investment Management, LLC and Metropolitan Life Insurance Company who are also filing 13F Holdings Reports. Each entity is filing its own 13F Holdings Report because each entity has investment discretion over certain 13(f) securities reported. All three 13F Holdings Report filers are under common control of their ultimate parent, MetLife, Inc., who is filing a 13F Notice Report.

Other Included Managers (1):

Num Name Location File Number
1 METLIFE INC New York, NY 028-18621